Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-11-04
2000-08-08
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546141, 546143, 546157, 546172, A61K 314709, A61P 1902, C07D40114
Patent
active
06100278&
ABSTRACT:
The invention relates compounds of formula ##STR1## in which R.sub.1 to R.sub.9, R.sub.16 and R.sub.17 are as defined in claim 1.
These compounds are pharmacologically active.
REFERENCES:
Robinson et al., Tetrahedron, 49(48), 1993, pp. 11329-11340.
Beilstein: Registry No. 6609829. (1994).
Beilstein: Registry No. 3458151. (1992).
Busson et al., J. Org. Chem., 43(23), 1978, pp. 4438-4441.
Beilstein: Registry No. 419229. (1993).
Carlson et al., J. Org. Chem., 31(7), 1966, pp. 2385-2386.
Beilstein: Registry No. 454128. (1993).
Burke et al., Exp. Opin. Ther. Patents, 5(4), 1995, pp. 331-339.
Wagner, Chemical Abstracts, vol. 107, No. 92532, 1987.
Ferrari Bernard
Gougat Jean
Muneaux Claude
Muneaux Yvette
Perreaut Pierre
Alexander Michael D.
Ramsuer Robert W.
Sanofi-Synthelabo
LandOfFree
N-(arylsulphonyl)amino acid derivatives, process for their prepa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(arylsulphonyl)amino acid derivatives, process for their prepa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(arylsulphonyl)amino acid derivatives, process for their prepa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1150515